The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
10 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,053,066 in first-year total cost, median $233,250.
Most frequent study sections
- Special Emphasis Panel[ZAI1 FDS-M (M1)]10
Most frequent institutions
- UNIVERSITY OF WASHINGTON3
- MAGIC LIFESCIENCE, INC.1
- RESEARCH INST NATIONWIDE CHILDREN'S HOSP1
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO1
- UNIVERSITY OF TEXAS AT AUSTIN1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2024 | Sensitive Treponema pallidum genome recovery through tiling amplicon sequencing1R21AI185726-01 | GRENINGER, ALEXANDER L | UNIVERSITY OF WASHINGTON, WA | $264,750 | ZAI1 |
| 2024 | Development of a Direct Diagnostic Test for Infectious and Congenital Syphilis1R21AI186005-01 | CAMERON, CAROLINE E | UNIVERSITY OF VICTORIA, BC | $260,760 | ZAI1 |
| 2024 | Pre-Analytic Factors affecting Molecular tests for Congenital Syphilis1R21AI185968-01 | ADHIKARI, EMILY HSORELLE, JEFFREY | UT SOUTHWESTERN MEDICAL CENTER, TX | $246,000 | ZAI1 |
| 2024 | Interrogating infant immune responses for diagnosis of congenital syphilis infection1R21AI186003-01 | SHIMAMURA, MASAKO | RESEARCH INST NATIONWIDE CHILDREN'S HOSP, OH | $234,000 | ZAI1 |
| 2024 | Rapid and Ultrasensitive aptamer-based detection technologies for T. pallidum1R21AI184484-01 | SALIPANTE, STEPHEN J | UNIVERSITY OF WASHINGTON, WA | $233,250 | ZAI1 |
| 2024 | Rapid Point-of-Care Detection of T. pallidum Resistance to Macrolides and Tetracyclines by Multiplexed Loop-mediated amplification (LAMP)1R21AI184749-01 | LIEBERMAN, JOSHUA ABRAHAM | UNIVERSITY OF WASHINGTON, WA | $233,250 | ZAI1 |
| 2024 | A Triad Approach Towards Improved Diagnostics for Maternal and Congenital Syphilis1R21AI185965-01 | BHADRA, SANCHITAHUBACH, RANDOLPH D | UNIVERSITY OF TEXAS AT AUSTIN, TX | $212,357 | ZAI1 |
| 2024 | Multi-omic approaches to identify novel biomarkers for the diagnosis of syphilis in pregnancy and assessment of treatment response1R21AI186006-01 | GAW, STEPHANIE LINA | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $205,000 | ZAI1 |
| 2024 | Development of a novel syphilis molecular diagnostic assay for a point-of-care multiplexed genital ulcer panel test on giant magnetoresistive biosensors1R21AI185972-01 | NG, ELAINE | MAGIC LIFESCIENCE, INC., CA | $163,698 | ZAI1 |
| 2024 | Released peptidoglycan fragments are a biomarker for early stages of syphilis1R21AI185998-01 | JUTRAS, BRANDON LYON | VIRGINIA POLYTECHNIC INST AND ST UNIV, VA | $1 | ZAI1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.